{"id":"https://openalex.org/W2334190875","doi":"https://doi.org/10.1016/j.juro.2014.02.1756","title":"MP60-02 PRETREATMENT NEUTROPHIL-TO-LYMPHOCYTE RATIO IS AN INDEPENDENT PREDICTOR OF ADVANCED PATHOLOGIC STAGE AND CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH UROTHELIAL CARCINOMA UNDERGOING RADICAL CYSTECTOMY","display_name":"MP60-02 PRETREATMENT NEUTROPHIL-TO-LYMPHOCYTE RATIO IS AN INDEPENDENT PREDICTOR OF ADVANCED PATHOLOGIC STAGE AND CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH UROTHELIAL CARCINOMA UNDERGOING RADICAL CYSTECTOMY","publication_year":2014,"publication_date":"2014-03-28","ids":{"openalex":"https://openalex.org/W2334190875","doi":"https://doi.org/10.1016/j.juro.2014.02.1756","mag":"2334190875"},"language":"en","primary_location":{"id":"doi:10.1016/j.juro.2014.02.1756","doi":"https://doi.org/10.1016/j.juro.2014.02.1756","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.juro.2014.02.1756","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005104565","display_name":"Boyd R. Viers","orcid":"https://orcid.org/0000-0003-2733-6623","observed_orcids":["https://orcid.org/0000-0003-2733-6623"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Boyd Viers","raw_affiliation_strings":["Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rochester, MN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077644150","display_name":"Stephen Anthony Boorjian","orcid":"https://orcid.org/0000-0002-8705-6650","observed_orcids":["https://orcid.org/0000-0002-8705-6650"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen Boorjian","raw_affiliation_strings":["Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rochester, MN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072217644","display_name":"Igor Frank","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Igor Frank","raw_affiliation_strings":["Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rochester, MN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018977927","display_name":"Robert Tarrell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Tarrell","raw_affiliation_strings":["Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rochester, MN","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078443392","display_name":"Prabin Bikram Thapa","orcid":"https://orcid.org/0000-0003-3304-2410","observed_orcids":["https://orcid.org/0000-0003-3304-2410"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Prabin Thapa","raw_affiliation_strings":["Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rochester, MN","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069162638","display_name":"Matthew K. Tollefson","orcid":"https://orcid.org/0000-0002-9960-4124","observed_orcids":["https://orcid.org/0000-0002-9960-4124"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew Tollefson","raw_affiliation_strings":["Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rochester, MN","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.25009421,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"191","issue":"4S","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12626","display_name":"Cancer, Stress, Anesthesia, and Immune Response","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neutrophil-to-lymphocyte-ratio","display_name":"neutrophil-to-lymphocyte ratio","score":0.9919999837875366},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.9359999895095825},{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.9509999752044678},{"id":"https://openalex.org/keywords/radical-cystectomy","display_name":"radical cystectomy","score":0.9990000128746033},{"id":"https://openalex.org/keywords/systemic-inflammation","display_name":"systemic inflammation","score":0.9020000100135803},{"id":"https://openalex.org/keywords/cancer-specific-survival","display_name":"cancer-specific survival","score":0.8930000066757202},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7289999723434448},{"id":"https://openalex.org/keywords/recurrence-free-survival","display_name":"recurrence-free survival","score":0.8519999980926514},{"id":"https://openalex.org/keywords/pathological-stage","display_name":"pathological stage","score":0.8579999804496765},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8999999761581421},{"id":"https://openalex.org/keywords/preoperative-inflammatory-markers","display_name":"preoperative inflammatory markers","score":0.6290000081062317},{"id":"https://openalex.org/keywords/lymphovascular-invasion","display_name":"lymphovascular invasion","score":0.8330000042915344},{"id":"https://openalex.org/keywords/lymph-node-metastasis","display_name":"lymph node metastasis","score":0.7009999752044678},{"id":"https://openalex.org/keywords/margin-status","display_name":"margin status","score":0.43799999356269836},{"id":"https://openalex.org/keywords/postoperative-complications","display_name":"postoperative complications","score":0.8460000157356262},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.7289999723434448},{"id":"https://openalex.org/keywords/adjuvant-chemotherapy","display_name":"adjuvant chemotherapy","score":0.5109999775886536}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9065917730331421},{"id":"https://openalex.org/C2775910329","wikidata":"https://www.wikidata.org/wiki/Q245995","display_name":"Cystectomy","level":4,"score":0.8320552110671997},{"id":"https://openalex.org/C2778740770","wikidata":"https://www.wikidata.org/wiki/Q6708283","display_name":"Lymphovascular invasion","level":4,"score":0.6826303005218506},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6587537527084351},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.6465985774993896},{"id":"https://openalex.org/C2778963024","wikidata":"https://www.wikidata.org/wiki/Q17132454","display_name":"Neutrophil to lymphocyte ratio","level":3,"score":0.6364153623580933},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.6177128553390503},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5662930607795715},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5222938060760498},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4765627682209015},{"id":"https://openalex.org/C3019882237","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Urothelial carcinoma","level":4,"score":0.47580796480178833},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.46234551072120667},{"id":"https://openalex.org/C2780091936","wikidata":"https://www.wikidata.org/wiki/Q17103890","display_name":"T-stage","level":3,"score":0.46163177490234375},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.39417773485183716},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.3024275004863739},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.138569176197052},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.11723434925079346},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.juro.2014.02.1756","doi":"https://doi.org/10.1016/j.juro.2014.02.1756","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.juro.2014.02.1756","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8299999833106995,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1989925694","https://openalex.org/W4380320588","https://openalex.org/W2028944115","https://openalex.org/W2602185078","https://openalex.org/W2296829825","https://openalex.org/W2600359837","https://openalex.org/W1983660988","https://openalex.org/W4214606897","https://openalex.org/W2062583192","https://openalex.org/W2602593037"],"abstract_inverted_index":{"You":[0],"have":[1],"accessJournal":[2],"of":[3,121,135,152,168,224,252,281,318,350,358,387],"UrologyBladder":[4],"Cancer:":[5],"Invasive":[6],"III1":[7],"Apr":[8],"2014MP60-02":[9],"PRETREATMENT":[10],"NEUTROPHIL-TO-LYMPHOCYTE":[11],"RATIO":[12],"IS":[13],"AN":[14],"INDEPENDENT":[15],"PREDICTOR":[16],"OF":[17],"ADVANCED":[18],"PATHOLOGIC":[19],"STAGE":[20],"AND":[21],"CANCER-SPECIFIC":[22],"SURVIVAL":[23],"IN":[24],"PATIENTS":[25],"WITH":[26],"UROTHELIAL":[27],"CARCINOMA":[28],"UNDERGOING":[29],"RADICAL":[30],"CYSTECTOMY":[31],"Boyd":[32,45,453],"Viers,":[33],"Stephen":[34,54,460],"Boorjian,":[35],"Igor":[36,63,467],"Frank,":[37],"Robert":[38,72,474],"Tarrell,":[39],"Prabin":[40,81,481],"Thapa,":[41],"and":[42,90,111,142,174,196,206,245,288,311,368,391,407,435],"Matthew":[43,91,488],"Tollefson":[44,93,489],"ViersBoyd":[46],"Viers":[47,454],"More":[48,57,66,75,84,94,455,462,469,476,483,490],"articles":[49,58,67,76,85,95,456,463,470,477,484,491],"by":[50,59,68,77,86,96,457,464,471,478,485,492],"this":[51,60,69,78,87,97,266,458,465,472,479,486,493],"author":[52,61,70,79,88,98,459,466,473,480,487,494],",":[53,62,71,80,89],"BoorjianStephen":[55],"Boorjian":[56,461],"FrankIgor":[64],"Frank":[65,468],"TarrellRobert":[73],"Tarrell":[74,475],"ThapaPrabin":[82],"Thapa":[83,482],"TollefsonMatthew":[92],"View":[99],"All":[100,496],"Author":[101,451],"Informationhttps://doi.org/10.1016/j.juro.2014.02.1756AboutPDF":[102],"ToolsAdd":[103],"to":[104,164,220],"favoritesDownload":[105],"CitationsTrack":[106],"CitationsPermissionsReprints":[107],"ShareFacebookTwitterLinked":[108],"InEmail":[109],"Introduction":[110],"Objectives":[112],"Pretreatment":[113],"neutrophil":[114],"lymphocyte":[115],"ratio":[116],"(NLR)":[117],"is":[118,381,399],"a":[119,133,230,256,272,355],"marker":[120],"systemic":[122],"inflammation":[123],"that":[124,271,377,419],"has":[125,156],"been":[126,158],"associated":[127,276,329,346,382,400],"with":[128,171,208,227,277,330,347,383,401],"adverse":[129,332],"oncologic":[130,143],"outcomes":[131,144,173],"in":[132,425],"variety":[134],"malignancies.":[136],"However,":[137],"the":[138,153,166,203,209,222],"relationship":[139],"between":[140],"NLR":[141,170,226,258,274,322,343,380,398,421],"following":[145,176],"radical":[146],"cystectomy":[147],"(RC)":[148],"for":[149,234,265,354,414,432],"urothelial":[150],"carcinoma":[151],"bladder":[154,319,363],"(UCB)":[155],"not":[157],"well":[159],"established.":[160],"Our":[161],"objective":[162],"was":[163,275,298,328,344],"evaluate":[165],"association":[167,223],"preoperative":[169,225,257,379,426],"clinicopathologic":[172],"survival":[175,198],"RC.":[177],"Methods":[178],"We":[179,375],"identified":[180],"912":[181],"patients":[182,254,307,411],"who":[183,316],"underwent":[184],"RC":[185,413],"without":[186],"neoadjuvant":[187,433],"chemotherapy":[188,434],"at":[189],"our":[190],"institution":[191],"between1994-2005.":[192],"Recurrence-free,":[193],"cancer-specific":[194,406],"(CSS)":[195],"overall":[197],"(OS)":[199],"were":[200,218],"estimated":[201],"using":[202],"Kaplan-Meier":[204],"method":[205],"compared":[207],"log-rank":[210],"test.":[211],"Multivariate":[212],"Cox":[213],"proportional":[214],"hazard":[215],"regression":[216],"models":[217],"used":[219],"analyze":[221],"outcomes,":[228],"as":[229],"continuous":[231],"variable,":[232],"adjusting":[233],"age,":[235],"gender,":[236],"performance":[237],"status,":[238],"pathologic":[239],"stage,":[240],"lymphovascular":[241],"invasion,":[242],"margin":[243],"status":[244],"early":[246],"postoperative":[247,296],"complication.":[248],"Results":[249],"A":[250],"total":[251],"569/912":[253],"had":[255],"\u2265":[259,323],"2.5,":[260],"an":[261],"established":[262],"prognostic":[263],"threshold":[264],"measure.":[267],"Indeed,":[268],"we":[269],"found":[270,376],"pre-operative":[273],"significantly":[278,331,384,402],"increased":[279,348,378,385,403],"risks":[280,349,386],"extravesical":[282],"tumor":[283,389],"extension":[284,390],"(OR":[285,292],"1.07;":[286,293],"p=0.027)":[287],"lymph":[289,392],"node":[290,393],"involvement":[291],"p=0.049).":[294],"Median":[295],"follow-up":[297],"10.9":[299],"years":[300],"(IQR":[301],"8.2-14.0),":[302],"during":[303],"which":[304],"time":[305],"323":[306],"experienced":[308],"disease":[309,351,404],"recurrence":[310,352],"624":[312],"died,":[313],"including":[314,430],"348":[315],"died":[317],"cancer.":[320],"Preoperative":[321],"2.5":[324,327],"versus":[325,336],"<":[326],"10-year":[333],"CSS":[334],"(53%":[335],"63%;":[337],"0=0.001).":[338],"Moreover,":[339],"on":[340],"multivariate":[341],"analysis,":[342],"independently":[345],"(HR":[353,365,371],"1-unit":[356],"increase":[357],"1.04;":[359,372],"p=0.049),":[360],"death":[361],"from":[362],"cancer":[364],"1.05;":[366],"p=0.0004)":[367],"all-cause":[369,408],"mortality":[370,409],"p=0.001).":[373],"Conclusions":[374],"locally-advanced":[388],"involvement.":[394],"In":[395],"addition,":[396],"higher":[397],"recurrence,":[405],"among":[410],"undergoing":[412],"UCB.":[415],"These":[416],"results":[417],"suggest":[418],"serum":[420],"may":[422],"be":[423],"useful":[424],"patient":[427],"risk":[428],"stratification,":[429],"consideration":[431],"clinical":[436],"trial":[437],"enrollment.":[438],"\u00a9":[439],"2014FiguresReferencesRelatedDetails":[440],"Volume":[441],"191Issue":[442],"4SApril":[443],"2014Page:":[444],"e633":[445],"Advertisement":[446,497,498],"Copyright":[447],"&":[448],"Permissions\u00a9":[449],"2014Metrics":[450],"Information":[452],"Expand":[495],"PDF":[499],"downloadLoading":[500],"...":[501]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}